DG

Daniel A. Gamache

AP Arrowhead Pharmaceuticals: 2 patents #4 of 33Top 15%
AR Arrowhead Research: 1 patents #2 of 5Top 40%
Overall (2016): #76,282 of 481,213Top 20%
3
Patents 2016

Issued Patents 2016

Showing 1–3 of 3 patents

Patent #TitleCo-InventorsDate
9453220 RNAi-mediated inhibition of phosphodiesterase type 4 for treatment of cAMP-related ocular disorders John M. Yanni, John E. Chatterton, Steven T. Miller 2016-09-27
9447419 RNAi-mediated inhibition of tumor necrosis factor α-related conditions John M. Yanni, Jon E. Chatterton, Diane Michelle Senchyna, Steven T. Miller 2016-09-20
9371529 RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions John M. Yanni, Jon E. Chatterton, Steven T. Miller 2016-06-21